← Eichor
Study identifier: NCT06791889 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Blood DdPCR for Early Identification and Dynamic Surveillance of Pathogenic Bacteria in ICU Septic Patients: a Single-centre, Prospective, Observational Study

Condition: Sepsis · Bloodstream Infections · Critically Ill Intensive Care Unit Patients  ·  Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

PhaseN/A
Planned participants60
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of this study is to investigate the efficacy of droplet digital PCR (ddPCR) in identifying pathogenic organisms in ICU sepsis patients, aiming to find a method that allows early identification of pathogenic organisms and dynamic surveillance in order to assess the association between pathogenic species and loads and clinical characteristics and outcomes.

This description comes directly from the study's public registry record.

Talk to the study team

You Shang, prof.  ·  008602785351606  ·  you_shanghust@163.com

Xiaobo Yang, prof.  ·  008602785351607  ·  want.tofly@aliyun.com

Always discuss trial participation with your own doctor first.

Locations (1)

Department of Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyWuhan, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06791889